BRG1-IN-1 (Compound 11d) is a potent BRG1 inhibitor that surpasses PFI-3 in sensitizing GBM cells to the antiproliferative and cell death-inducing effects of Temozolomide in vitro, and enhances Temozolomides inhibitory effect on subcutaneous GBM tumor growth[1].
Molecular Weight:
322.38
CAS Number:
[2616813-99-9]
Formula:
C20H19FN2O
Target:
Others
T60870
* VAT and and shipping costs not included. Errors and price changes excepted
